{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:42:09Z","timestamp":1779381729038,"version":"3.53.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Ulcerative colitis (UC) is an autoimmune disease of unknown etiology, sometimes associated with anemia and thrombocytosis. Platelets (PLTs) play a role in amplifying inflammatory and immune responses in chronic inflammation. This study discusses the diagnosis and treatment of a case of UC combined with secondary thrombocytosis and reviews the relevant literature. We report an interaction between thrombocytosis and UC to raise clinicians\u2019 awareness of this condition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>In the current report, we discuss the case of a 30-year-old female patient who presented with frequent diarrhea and thrombocytosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Severe UC combined with intestinal infection was diagnosed based on colonoscopy and intestinal biopsy. The patient had a PLT count &gt;450\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L and was diagnosed with reactive thrombocytosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions and outcomes:<\/jats:title>\n            <jats:p>The patient was discharged from the hospital in remission after receiving vedolizumab and anticoagulant treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>In patients with severe UC with thrombocytosis, clinicians should pay attention to PLTs promoting inflammatory progression, as well as screening for venous thromboembolism risk and prophylactic anti-venous thromboembolism therapy at the time of dosing to avoid adverse effects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033784","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:01:39Z","timestamp":1684450899000},"page":"e33784","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Ulcerative colitis and thrombocytosis: Case report and literature review"],"prefix":"10.1097","volume":"102","author":[{"given":"Yaqi","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Jining Medical University, Jining, Shandong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehuai","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Pathology Department, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7803-605X","authenticated-orcid":false,"given":"Guangxi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.118.039345","article-title":"Novel role for the AnxA1-Fpr2\/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation.","volume":"140","author":"Senchenkova","year":"2019","journal-title":"Circulation"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3390\/antiox9050375","article-title":"Time-dependent indirect antioxidative effects of oat beta-glucans on peripheral blood parameters in the animal model of colon inflammation.","volume":"9","author":"Kopiasz","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.2018893594","article-title":"Platelet hyaluronidase-2 regulates the early stages of inflammatory disease in colitis.","volume":"134","author":"Petrey","year":"2019","journal-title":"Blood"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/advances\/nmaa145","article-title":"Association of dietary fiber, fruit, and vegetable consumption with risk of inflammatory bowel disease: a systematic review and meta-analysis.","volume":"12","author":"Milajerdi","year":"2021","journal-title":"Adv Nutr"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"756978","DOI":"10.3389\/fphar.2021.756978","article-title":"Modified gegen qinlian decoction regulates Treg\/Th17 balance to ameliorate DSS-induced acute experimental colitis in mice by altering the gut microbiota.","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1542-3565(05)00154-0","article-title":"Thrombosis and inflammatory bowel disease.","volume":"3","author":"Irving","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/ibd\/izy063","article-title":"Adverse reactions after intravenous iron infusion among inflammatory bowel disease patients in the United States, 2010-2014.","volume":"24","author":"Akhuemonkhan","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.3390\/nu13114008","article-title":"Iron deficiency anemia in inflammatory bowel diseases \u2013 a narrative review.","volume":"13","author":"Mahadea","year":"2021","journal-title":"Nutrients"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"818111","DOI":"10.3389\/fmicb.2022.818111","article-title":"Fecal microbiota transplantation ameliorates active ulcerative colitis by downregulating pro-inflammatory cytokines in mucosa and serum.","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.2147\/IJN.S174146","article-title":"Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis.","volume":"13","author":"Dou","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"8543720","DOI":"10.1155\/2022\/8543720","article-title":"Interleukin-22 ameliorates dextran sulfate sodium-induced colitis through the upregulation of lncRNA-UCL to accelerate claudin-1 expression via sequestering miR-568 in mice.","volume":"2022","author":"He","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3390\/ijms20051069","article-title":"HBD inhibits the development of colitis-associated cancer in mice via the IL-6R\/STAT3 signaling pathway.","volume":"20","author":"Deng","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMra035363","article-title":"Thrombocytosis.","volume":"350","author":"Schafer","year":"2004","journal-title":"N Engl J Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cgh.2019.12.043","article-title":"Shedding light on hemostasis in patients with inflammatory bowel diseases.","volume":"19","author":"Lagrange","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0049-3848(97)00183-7","article-title":"Persistence of hemostatic alterations in patients affected by Crohn\u2019s disease after bowel surgery.","volume":"87","author":"Chiarantini","year":"1997","journal-title":"Thromb Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1055\/s-0035-1556590","article-title":"Hypercoagulability and platelet abnormalities in inflammatory bowel disease.","volume":"41","author":"Senchenkova","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.3748\/wjg.v20.i12.3180","article-title":"Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.","volume":"20","author":"Voudoukis","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-015-0044-2","article-title":"Thrombosis in inflammatory bowel diseases: what\u2019s the link?","volume":"13","author":"Giannotta","year":"2015","journal-title":"Thromb J"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bjp.0707364","article-title":"Novel uses for anti-platelet agents as anti-inflammatory drugs.","volume":"152","author":"Pitchford","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5604\/17322693.1199305","article-title":"Markers of inflammation, activation of blood platelets and coagulation disorders in inflammatory bowel diseases.","volume":"70","author":"Matowicka-Karna","year":"2016","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/pr.117.014530","article-title":"Platelet signaling and disease: targeted therapy for thrombosis and other related diseases.","volume":"70","author":"Yeung","year":"2018","journal-title":"Pharmacol Rev"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/apt.15286","article-title":"A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease.","volume":"49","author":"McCurdy","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1361.058","article-title":"Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications.","volume":"1051","author":"Twig","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/gut.52.10.1435","article-title":"Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.","volume":"52","author":"Danese","year":"2003","journal-title":"Gut"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/1319-3767.41743","article-title":"Assessment of thrombophilic abnormalities during the active state of inflammatory bowel disease.","volume":"14","author":"Maher","year":"2008","journal-title":"Saudi J Gastroenterol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3748\/wjg.v26.i12.1231","article-title":"Venous thromboembolism in inflammatory bowel disease.","volume":"26","author":"Cheng","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1572-0241.2003.04026.x","article-title":"Venous thromboembolism in inflammatory bowel disease.","volume":"99","author":"Solem","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.cgh.2015.03.029","article-title":"Persistent or recurrent anemia is associated with severe and disabling inflammatory bowel disease.","volume":"13","author":"Koutroubakis","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrgastro.2013.117","article-title":"Extraintestinal manifestations and complications in IBD.","volume":"10","author":"Ott","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/MIB.0b013e318281f4db","article-title":"Iron deficiency generates secondary thrombocytosis and platelet activation in IBD.","volume":"19","author":"Kulnigg-Dabsch","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e34520","DOI":"10.1371\/journal.pone.0034520","article-title":"Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia.","volume":"7","author":"Kulnigg-Dabsch","year":"2012","journal-title":"PLoS One"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.pop.2011.05.008","article-title":"Acute infectious diarrhea.","volume":"38","author":"McClarren","year":"2011","journal-title":"Prim Care"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial.","volume":"2","author":"Truelove","year":"1955","journal-title":"Br Med J"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0163-4453(05)80006-4","article-title":"The platelet count as a simple measure to distinguish inflammatory bowel disease from infective diarrhoea.","volume":"22","author":"Harries","year":"1991","journal-title":"J Infect"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/17474124.2019.1671822","article-title":"Microbiota and mucosal defense in IBD: an update.","volume":"13","author":"Stange","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.meg.0000131040.38607.09","article-title":"Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool.","volume":"16","author":"Mylonaki","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1590\/1806-9282.65.4.547","article-title":"Ulcerative colitis \u2013 treatment with biologicals.","volume":"65","author":"Teixeira","year":"2019","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jama.2020.11583","article-title":"Ulcerative colitis in adults.","volume":"324","author":"Glick","year":"2020","journal-title":"JAMA"},{"key":"R41-20250504","first-page":"546","article-title":"Arterial thrombosis with anti-phospholipid antibodies induced by infliximab.","volume":"17","author":"Nosbaum","year":"2007","journal-title":"Eur J Dermatol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cgh.2020.10.003","article-title":"Comparative safety and effectiveness of vedolizumab to tumor necrosis factor antagonist therapy for ulcerative colitis.","volume":"20","author":"Lukin","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis.","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gutjnl-2015-311079","article-title":"The safety of vedolizumab for ulcerative colitis and Crohn\u2019s disease.","volume":"66","author":"Colombel","year":"2017","journal-title":"Gut"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:03:32Z","timestamp":1746324212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":44,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033784","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}